Many Elderly CHD Patients Not Taking Statins

Share this content:
Many Elderly CHD Patients Not Taking Statins
Many Elderly CHD Patients Not Taking Statins

TUESDAY, Oct. 20, 2015 (HealthDay News) -- High numbers of elderly patients with coronary heart disease (CHD) are not being treated with a statin, according to a study published in the Oct. 27 issue of the Journal of the American College of Cardiology.

Vera Bittner, M.D., M.S.P.H., from the University of Alabama at Birmingham, and colleagues evaluated trends between 2007 and 2011 for statin and non-statin lipid-lowering therapy (niacin, fibrates, bile acid sequestrants, and ezetimibe) use among Medicare beneficiaries with CHD. A random, national sample of 5 percent of Medicare beneficiaries (310,091 participants) was used to create 20 cohorts, representing calendar quarters.

The researchers found that statin use increased from 53.1 to 58.8 percent between 2007 and 2011. Ezetimibe use declined from its peak of 18.4 percent in statin users and 5.0 percent in non-statin users to 6.2 and 2.4 percent, respectively, by the end of 2011. Over the study period, fibrate use increased from 4.2 to 5.0 percent, bile acid sequestrants did not change significantly, and niacin use increased initially from 1.5 to 2.4 percent and then declined in late 2011. Among those of older age, African-Americans, patients with heart failure, and patients with a higher Charlson comorbidity score, use of non-statin lipid-lowering therapy was less common, while it was more common among men and patients with diabetes, those who had cardiologist visits, and those taking statins.

"Declining ezetimibe and niacin use but not fibrate therapy among Medicare beneficiaries with CHD coincides with negative clinical trial results for these agents," the authors write.

Several authors disclosed financial ties to pharmaceutical companies, including Amgen, which funded the study.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »